Management of severe covid-19: progress and promise, BMJ

This BMJ editorial outlines the current therapeutic approaches noting there is no evidence to support vitamins C and D, zinc, lopinavir-ritonavir, colchicine, interferons, fluvoxamine, ivermectin, and convalescent plasma; and survival benefit only reported with glucocorticoids.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news